Risk stratification after acute myocardial infarction by means of exercise two-dimensional echocardiography
References (28)
- et al.
The high risk patient after recovery from myocardial infarction: recognition and management
J Am Coll Cardiol
(1983) - et al.
Comparison of clinical and treadmill variables for the prediction of outcome after myocardial infarction
J Am Coll Cardiol
(1984) - et al.
Comparative value of maximal treadmill testing, exercise thallium myocardial perfusion scintigraphy and exercise radionuclide ventriculography for distinguishing high- and low-risk patients soon after acute myocardial infarction
Am J Cardiol
(1984) - et al.
Exercise echocardiography: a clinically practical addition in the evaluation of coronary artery disease
J Am Coll Cardiol
(1983) - et al.
Value of early two dimensional echocardiography in patients with acute myocardial infarction
Am J Cardiol
(1982) - et al.
The role of prehospital discharge two-dimensional echocardiography in determining the prognosis of survivors of first myocardial infarction
Am Heart J
(1985) - et al.
Prognostic value of predischarge 2-dimensional echocardiogram after acute myocardial infarction
Am J Cardiol
(1984) - et al.
Usefulness of two-dimensional exercise echocardiography shortly after myocardial infarction
Am J Cardiol
(1986) - et al.
Predicting the extent and location of coronary artery disease during the early postinfarction period by quantitative thallium-201 scintigraphy
Am J Cardiol
(1981) - et al.
Evaluation of patients after acute myocardial infarction. Indications for cardiac catheterization and surgical intervention
N Engl J Med
(1982)
Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery
N Engl J Med
Prognostic value of exercise testing soon after myocardial infarction
N Engl J Med
The prognostic significance of serial exercise testing after myocardial infarction
Circulation
Exercise testing early after myocardial infarction: predictive value for subsequent unstable angina and death
Am J Cardiol
Cited by (131)
Exercise Echocardiography
2008, Practice of Clinical Echocardiography, Thrid EditionHarvey Feigenbaum: A Retrospective
2008, Journal of the American Society of EchocardiographyAmerican Society of Echocardiography Recommendations for Performance, Interpretation, and Application of Stress Echocardiography
2007, Journal of the American Society of EchocardiographyCitation Excerpt :Stress echocardiography can be performed safely early after myocardial infarction and provides not only assessment of global and regional ventricular function, but can detect the presence and extent of residual myocardial ischemia.176 Several studies have confirmed that the extent of residual ischemia is related to adverse cardiac outcomes in this setting and provides information incremental to that obtained by exercise ECG177 or angiography.178-181 The incremental prognostic value of stress echocardiography is preserved in patients with abnormal LV function.182
Noninvasive assessment of coronary artery disease in diabetic patients: The role of stress echocardiography
2006, Canadian Journal of CardiologyLong-term prognostic importance of transient left ventricular dilation during pharmacologic stress echocardiography
2005, Journal of the American Society of EchocardiographyCitation Excerpt :To our knowledge, this is the first study aimed to elucidate whether TID during SE is an independent long-term prognostic marker when evaluating ischemic patients. Previous studies have demonstrated that the presence of ischemia evaluated using SE or scintigraphy is related to the development of future cardiac events.11-23 Furthermore, the discovery of extensive myocardial ischemia is associated with an even higher event rate23 and the presence of LV TID during stress scintigraphy is an useful predictor of cardiac events.24
Risk stratification after acute myocardial infarction
2003, Revista Espanola de Cardiologia
- 1
Supported in part by the Herman C. Krannert Fund, Indianapolis, Ind.; grants HL-06308 and HL-07182 and Clinical Investigator Award HL-01041 (Dr. Armstrong) from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.; the American Heart Association, Indiana Affiliate, Indianapolis, Ind.; and the Whitaker Foundation, Camp Hill, Pa.